Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988 Nov;72(11):829-34.
doi: 10.1136/bjo.72.11.829.

Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy

L Ficker  1 , G Vafidis, A While, P Leaver
Affiliations
Clinical Trial

Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy

L Ficker et al. Br J Ophthalmol. 1988 Nov.

Abstract

In a prospective randomised trial of argon laser photocoagulation in the management of central serous retinopathy, long-term follow-up (6.4 to 12.1 years) revealed no evidence that treatment significantly influenced the visual outcome as measured by the Snellen chart and by the Farnsworth-Munsell 100-hue test. Treatment did not reduce either the recurrence rate or the prevalence of chronic disease. Complications of treatment were uncommon. The justification for argon laser photocoagulation appears to be limited to the hastening of symptomatic relief by earlier resolution of serous detachment.

PubMed Disclaimer

References

    1. Trans Ophthalmol Soc U K. 1977 Sep;97(4):656-61 - PubMed
    1. Br J Ophthalmol. 1984 Nov;68(11):815-20 - PubMed
    1. Arch Ophthalmol. 1968 Feb;79(2):166-9 - PubMed
    1. Eye (Lond). 1987;1 ( Pt 1):120-5 - PubMed
    1. Trans Am Acad Ophthalmol Otolaryngol. 1965 Jul-Aug;69:605-13 - PubMed

Publication types